Effect of desferrioxamine on the development of hexachlorobenzene-induced porphyria

The present work deals with the effect of desferrioxamine (DP) on hexachlorobenzene (HCB)-induced porphyria in female rats with the purpose of further investigation of the role of iron in the development of this porphyria. The results obtained show that the repeated injection of DF (three times a we...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: de Calmanovici, R.W., Billi, S.C., Sldonatti, C.A., De Viale, l.C.S.M.
Formato: JOUR
Materias:
rat
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_00062952_v35_n14_p2399_deCalmanovici
Aporte de:
id todo:paper_00062952_v35_n14_p2399_deCalmanovici
record_format dspace
spelling todo:paper_00062952_v35_n14_p2399_deCalmanovici2023-10-03T14:04:14Z Effect of desferrioxamine on the development of hexachlorobenzene-induced porphyria de Calmanovici, R.W. Billi, S.C. Sldonatti, C.A. De Viale, l.C.S.M. deferoxamine hexachlorobenzene iron porphyrin animal cell animal experiment drug comparison drug dose drug efficacy intramuscular drug administration liver methodology nonhuman priority journal rat topical drug administration urinary tract 5-Aminolevulinate Synthetase Animal Body Weight Carboxy-Lyases Chlorobenzenes Deferoxamine Disease Models, Animal Female Hexachlorobenzene Iron Liver Organ Weight Porphyria Porphyrins Rats Skin Diseases Support, Non-U.S. Gov't The present work deals with the effect of desferrioxamine (DP) on hexachlorobenzene (HCB)-induced porphyria in female rats with the purpose of further investigation of the role of iron in the development of this porphyria. The results obtained show that the repeated injection of DF (three times a week: 100 mg/kg each i.m.) delayed and diminished remarkably the urinary excretion of precursors and porphyrins as well as the accumulation of the latter in liver promoted by HCB (1 g/kg daily given by stomach tube). This was probably due to attenuation by DF of the alterations produced by the fungicide in the two key enzymes: porphyrinogen carboxy-lyase (PCL) and δ-aminolaevulinate synthase (ALA-S). In fact, DF by reducing liver iron levels produced a smaller decrease of the target enzyme (PCL) and a concomitant smaller induction of ALA-S. DF alone did not modify any of these variables or the liver to body weight ratio. DF added at 10-2 and 10-3 M to the incubation media of ALA-S and PCL did not alter either of the enzymatic activities, whether in normal or HCB-porphyric preparations. The results obtained show that DF improved the biochemical picture during HCB porphyria. They suggest that iron plays an indirect role in the decrease of PCL enzyme, possibly at the HCB metabolization step. A common iron-involving mechanism for the production of porphyria by different chlorinated compounds is suggested. © 1986. Fil:Billi, S.C. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_00062952_v35_n14_p2399_deCalmanovici
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic deferoxamine
hexachlorobenzene
iron
porphyrin
animal cell
animal experiment
drug comparison
drug dose
drug efficacy
intramuscular drug administration
liver
methodology
nonhuman
priority journal
rat
topical drug administration
urinary tract
5-Aminolevulinate Synthetase
Animal
Body Weight
Carboxy-Lyases
Chlorobenzenes
Deferoxamine
Disease Models, Animal
Female
Hexachlorobenzene
Iron
Liver
Organ Weight
Porphyria
Porphyrins
Rats
Skin Diseases
Support, Non-U.S. Gov't
spellingShingle deferoxamine
hexachlorobenzene
iron
porphyrin
animal cell
animal experiment
drug comparison
drug dose
drug efficacy
intramuscular drug administration
liver
methodology
nonhuman
priority journal
rat
topical drug administration
urinary tract
5-Aminolevulinate Synthetase
Animal
Body Weight
Carboxy-Lyases
Chlorobenzenes
Deferoxamine
Disease Models, Animal
Female
Hexachlorobenzene
Iron
Liver
Organ Weight
Porphyria
Porphyrins
Rats
Skin Diseases
Support, Non-U.S. Gov't
de Calmanovici, R.W.
Billi, S.C.
Sldonatti, C.A.
De Viale, l.C.S.M.
Effect of desferrioxamine on the development of hexachlorobenzene-induced porphyria
topic_facet deferoxamine
hexachlorobenzene
iron
porphyrin
animal cell
animal experiment
drug comparison
drug dose
drug efficacy
intramuscular drug administration
liver
methodology
nonhuman
priority journal
rat
topical drug administration
urinary tract
5-Aminolevulinate Synthetase
Animal
Body Weight
Carboxy-Lyases
Chlorobenzenes
Deferoxamine
Disease Models, Animal
Female
Hexachlorobenzene
Iron
Liver
Organ Weight
Porphyria
Porphyrins
Rats
Skin Diseases
Support, Non-U.S. Gov't
description The present work deals with the effect of desferrioxamine (DP) on hexachlorobenzene (HCB)-induced porphyria in female rats with the purpose of further investigation of the role of iron in the development of this porphyria. The results obtained show that the repeated injection of DF (three times a week: 100 mg/kg each i.m.) delayed and diminished remarkably the urinary excretion of precursors and porphyrins as well as the accumulation of the latter in liver promoted by HCB (1 g/kg daily given by stomach tube). This was probably due to attenuation by DF of the alterations produced by the fungicide in the two key enzymes: porphyrinogen carboxy-lyase (PCL) and δ-aminolaevulinate synthase (ALA-S). In fact, DF by reducing liver iron levels produced a smaller decrease of the target enzyme (PCL) and a concomitant smaller induction of ALA-S. DF alone did not modify any of these variables or the liver to body weight ratio. DF added at 10-2 and 10-3 M to the incubation media of ALA-S and PCL did not alter either of the enzymatic activities, whether in normal or HCB-porphyric preparations. The results obtained show that DF improved the biochemical picture during HCB porphyria. They suggest that iron plays an indirect role in the decrease of PCL enzyme, possibly at the HCB metabolization step. A common iron-involving mechanism for the production of porphyria by different chlorinated compounds is suggested. © 1986.
format JOUR
author de Calmanovici, R.W.
Billi, S.C.
Sldonatti, C.A.
De Viale, l.C.S.M.
author_facet de Calmanovici, R.W.
Billi, S.C.
Sldonatti, C.A.
De Viale, l.C.S.M.
author_sort de Calmanovici, R.W.
title Effect of desferrioxamine on the development of hexachlorobenzene-induced porphyria
title_short Effect of desferrioxamine on the development of hexachlorobenzene-induced porphyria
title_full Effect of desferrioxamine on the development of hexachlorobenzene-induced porphyria
title_fullStr Effect of desferrioxamine on the development of hexachlorobenzene-induced porphyria
title_full_unstemmed Effect of desferrioxamine on the development of hexachlorobenzene-induced porphyria
title_sort effect of desferrioxamine on the development of hexachlorobenzene-induced porphyria
url http://hdl.handle.net/20.500.12110/paper_00062952_v35_n14_p2399_deCalmanovici
work_keys_str_mv AT decalmanovicirw effectofdesferrioxamineonthedevelopmentofhexachlorobenzeneinducedporphyria
AT billisc effectofdesferrioxamineonthedevelopmentofhexachlorobenzeneinducedporphyria
AT sldonattica effectofdesferrioxamineonthedevelopmentofhexachlorobenzeneinducedporphyria
AT devialelcsm effectofdesferrioxamineonthedevelopmentofhexachlorobenzeneinducedporphyria
_version_ 1807324282039042048